Sign In

Login

Password

Forgot Password ? Sign Up

Schizofrenia (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Schizofrenia" in Polish language version.

refsWebsite
Global rank Polish rank
75doi.org
2nd place
6th place
74nih.gov
4th place
7th place
4archive.is
87th place
5th place
4worldcat.org
5th place
2nd place
2web.archive.org
1st place
1st place
2nice.org.uk
3,258th place
2,944th place
1icanfeelbetter.org
low place
low place
1who.int
195th place
256th place
1fherehab.com
low place
low place
1livingwithschizophreniauk.org
low place
low place
1psychiatryonline.org
4,032nd place
2,809th place
1webcitation.org
24th place
107th place
1mp.pl
8,738th place
165th place
1psychodyssey.net
low place
low place

archive.is

doi.org

dx.doi.org

  • D. Castle i inni, The incidence of operationally defined schizophrenia in Camberwell, 1965-84, „The British Journal of Psychiatry”, 159, 1991, s. 790–794, DOI: 10.1192/bjp.159.6.790, PMID: 1790446.
  • Dinesh Bhugra, The global prevalence of schizophrenia, „PLoS Medicine”, 2 (5), 2005, art. nr e151, DOI: 10.1371/journal.pmed.0020151, PMID: 15916460, PMCID: PMC1140960.
  • Elliot M. Goldner i inni, Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature, „Canadian Journal of Psychiatry”, 47 (9), 2002, s. 833–843, DOI: 10.1177/070674370204700904, PMID: 12500753.
  • Georg Schomerus i inni, The association of schizophrenia with split personality is not an ubiquitous phenomenon: results from population studies in Russia and Germany, „Social Psychiatry and Psychiatric Epidemiology”, 42 (10), 2007, s. 780–786, DOI: 10.1007/s00127-007-0235-7, PMID: 17660932.
  • Joachim Kowalski, Katarzyna Szaulińska, Marek Jarema, In search of a definition of the term "psychotic process" - thoughts and doubts, „Psychiatria Polska”, 51 (2), 2017, s. 383–386, DOI: 10.12740/pp/69387, ISSN 0033-2674 [dostęp 2021-05-25] (pol.).
  • S. Brown, H. Inskip, B. Barraclough, Causes of the excess mortality of schizophrenia, „The British Journal of Psychiatry”, 177, 2000, s. 212–217, DOI: 10.1192/bjp.177.3.212, PMID: 11040880.
  • A. Jablensky i inni, Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study, „Psychological Medicine. Monograph Supplement”, 20, 1992, s. 1–97, DOI: 10.1017/s0264180100000904, PMID: 1565705.
  • James B. Kirkbride i inni, Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study, „Archives of General Psychiatry”, 63 (3), 2006, s. 250–258, DOI: 10.1001/archpsyc.63.3.250, PMID: 16520429.
  • James B. Kirkbride i inni, Neighbourhood variation in the incidence of psychotic disorders in Southeast London, „Social Psychiatry and Psychiatric Epidemiology”, 42 (6), 2007, s. 438–445, DOI: 10.1007/s00127-007-0193-0, PMID: 17473901.
  • John McGrath i inni, A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology, „BMC Medicine”, 2, 2004, s. 13, DOI: 10.1186/1741-7015-2-13, PMID: 15115547, PMCID: PMC421751.
  • Paul J. Scully i inni, First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years, „The British Journal of Psychiatry. Supplement”, 43, 2002, s3–9, DOI: 10.1192/bjp.181.43.s3, PMID: 12271797.
  • Geoffrey Davies i inni, A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia, „Schizophrenia Bulletin”, 29 (3), 2003, s. 587–593, DOI: 10.1093/oxfordjournals.schbul.a007030, PMID: 14609251.
  • T.B. Ustün i inni, Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group, „The Lancet”, 354 (9173), 1999, s. 111–115, DOI: 10.1016/s0140-6736(98)07507-2, PMID: 10408486.
  • S. Kumra i inni, Childhood-onset schizophrenia: research update, „Canadian Journal of Psychiatry”, 46 (10), 2001, s. 923–930, DOI: 10.1177/070674370104601004, PMID: 11816313.
  • H. Remschmidt, F.M. Theisen, Schizophrenia and related disorders in children and adolescents, „Journal of Neural Transmission. Supplementum” (69), 2005, s. 121–141, DOI: 10.1007/3-211-31222-6_7, PMID: 16355606.
  • Aksel Bertelsen, Schizophrenia and related disorders: experience with current diagnostic systems, „Psychopathology”, 35 (2–3), 2002, s. 89–93, DOI: 10.1159/000065125, PMID: 12145490.
  • Jeffrey A. Lieberman i inni, Effectiveness of antipsychotic drugs in patients with chronic schizophrenia, „The New England Journal of Medicine”, 353 (12), 2005, s. 1209–1223, DOI: 10.1056/NEJMoa051688, PMID: 16172203.
  • R.A. Dickson i inni, Risperidone-induced prolactin elevations in premenopausal women with schizophrenia, „The American Journal of Psychiatry”, 152 (7), 1995, s. 1102–1103, DOI: 10.1176/ajp.152.7.1102b, PMID: 7540803.
  • Jambur Ananth i inni, Neuroleptic malignant syndrome and atypical antipsychotic drugs, „The Journal of Clinical Psychiatry”, 65 (4), 2004, s. 464–470, DOI: 10.4088/jcp.v65n0403, PMID: 15119907.
  • Jason M Noel, Cherry W Jackson, ASHP therapeutic position statement on the use of antipsychotic medications in the treatment of adults with schizophrenia and schizoaffective disorder, „American Journal of Health-System Pharmacy”, 77 (24), 2020, s. 2114–2132, DOI: 10.1093/ajhp/zxaa303, ISSN 1079-2082, PMID: 32871013, PMCID: PMC7499485.
  • American Psychiatric Association, The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia, wyd. 3, American Psychiatric Association Publishing, 1 września 2020, DOI: 10.1176/appi.books.9780890424841, ISBN 978-0-89042-484-1.
  • Stefan Leucht i inni, New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis, „The Lancet”, 361 (9369), 2003, s. 1581–1589, DOI: 10.1016/S0140-6736(03)13306-5, PMID: 12747876.
  • H.Y. Meltzer, Treatment-resistant schizophrenia--the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI: 10.1185/03007999709113338, PMID: 9524789.
  • K. Wahlbeck, M. Cheine, M.A. Essali, Clozapine versus typical neuroleptic medication for schizophrenia, „The Cochrane Database of Systematic Reviews” (2), 2000, CD000059, DOI: 10.1002/14651858.CD000059, PMID: 10796289.
  • Steven J. Haas i inni, Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003, „Drug Safety”, 30 (1), 2007, s. 47–57, DOI: 10.2165/00002018-200730010-00005, PMID: 17194170.
  • Marlene P. Freeman i inni, Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry, „The Journal of Clinical Psychiatry”, 67 (12), 2006, s. 1954–1967, DOI: 10.4088/jcp.v67n1217, PMID: 17194275.
  • José Salavert i inni, Association Between Vitamin D Status and Schizophrenia A First Psychotic Episode Study, „The Journal of Nervous and Mental Disease”, 205(5), 2017, s. 409–412, DOI: 10.1097/NMD.0000000000000670.
  • Mark Moran, Psychosocial Treatment Often Missing From Schizophrenia Regimens, „Psychiatric News”, 40 (22), 2005, s. 24–37, DOI: 10.1176/pn.40.22.0024b (ang.).
  • I. Cormac, C. Jones, C. Campbell, Cognitive behaviour therapy for schizophrenia, „The Cochrane Database of Systematic Reviews” (1), 2002, art. nr CD000524, DOI: 10.1002/14651858.CD000524, PMID: 11869579.
  • G. Zimmermann i inni, The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis, „Schizophrenia Research”, 77 (1), 2005, s. 1–9, DOI: 10.1016/j.schres.2005.02.018, PMID: 16005380.
  • Til Wykes i inni, Effects on the brain of a psychological treatment: cognitive remediation therapy: functional magnetic resonance imaging in schizophrenia, „The British Journal of Psychiatry”, 181, 2002, s. 144–152, DOI: 10.1017/s0007125000161872, PMID: 12151286.
  • Gerard E. Hogarty i inni, Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior, „Archives of General Psychiatry”, 61 (9), 2004, s. 866–876, DOI: 10.1001/archpsyc.61.9.866, PMID: 15351765.
  • William R. McFarlane i inni, Family psychoeducation and schizophrenia: a review of the literature, „Journal of Marital and Family Therapy”, 29 (2), 2003, s. 223–245, DOI: 10.1111/j.1752-0606.2003.tb01202.x, PMID: 12728780.
  • Shirley M. Glynn, Amy N. Cohen, Noosha Niv, New challenges in family interventions for schizophrenia, „Expert Review of Neurotherapeutics”, 7 (1), 2007, s. 33–43, DOI: 10.1586/14737175.7.1.33, PMID: 17187495.
  • Alex Kopelowicz, Robert Paul Liberman, Roberto Zarate, Recent advances in social skills training for schizophrenia, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, s. S12–S23, DOI: 10.1093/schbul/sbl023, PMID: 16885207, PMCID: PMC2632540.
  • Nakul Talwar i inni, Music therapy for in-patients with schizophrenia: exploratory randomised controlled trial, „The British Journal of Psychiatry”, 189, 2006, s. 405–409, DOI: 10.1192/bjp.bp.105.015073, PMID: 17077429.
  • Dafna Regev, Liat Cohen-Yatziv, Effectiveness of art therapy with adult clients in 2018—what progress has been made?, „Frontiers in Psychology”, 9, 2018, DOI: 10.3389/fpsyg.2018.01531, ISSN 1664-1078, PMID: 30210388, PMCID: PMC6124538.
  • J. Greenhalgh i inni, Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies, „Health Technology Assessment”, 9 (9), 2005, s. 1–156, DOI: 10.3310/hta9090, PMID: 15774232.
  • George A. Mashour, Erin E. Walker, Robert L. Martuza, Psychosurgery: past, present, and future, „Brain Research. Brain Research Reviews”, 48 (3), 2005, s. 409–419, DOI: 10.1016/j.brainresrev.2004.09.002, PMID: 15914249 [dostęp 2020-05-01].
  • Paula Goering i inni, Who uses consumer-run self-help organizations?, „The American Journal of Orthopsychiatry”, 76 (3), 2006, s. 367–373, DOI: 10.1037/0002-9432.76.3.367, PMID: 16981815.
  • L. Davidson, T.H. McGlashan, The varied outcomes of schizophrenia, „Canadian Journal of Psychiatry”, 42 (1), 1997, s. 34–43, DOI: 10.1177/070674379704200105, PMID: 9040921.
  • G. Harrison i inni, Recovery from psychotic illness: a 15- and 25-year international follow-up study, „The British Journal of Psychiatry”, 178, 2001, s. 506–517, DOI: 10.1192/bjp.178.6.506, PMID: 11388966.
  • C.M. Harding i inni, The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia, „The American Journal of Psychiatry”, 144 (6), 1987, s. 727–735, DOI: 10.1176/ajp.144.6.727, PMID: 3591992.
  • Delbert G. Robinson i inni, Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder, „The American Journal of Psychiatry”, 161 (3), 2004, s. 473–479, DOI: 10.1176/appi.ajp.161.3.473, PMID: 14992973.
  • Carol A. Harvey i inni, The Camden Schizophrenia Surveys. III: Five-year outcome of a sample of individuals from a prevalence survey and the importance of social relationships, „The International Journal of Social Psychiatry”, 53 (4), 2007, s. 340–356, DOI: 10.1177/0020764006074529, PMID: 17703650.
  • K. Hopper, J. Wanderling, Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia, „Schizophrenia Bulletin”, 26 (4), 2000, s. 835–846, DOI: 10.1093/oxfordjournals.schbul.a033498, PMID: 11087016.
  • P. Bebbington, L. Kuipers, The predictive utility of expressed emotion in schizophrenia: an aggregate analysis, „Psychological Medicine”, 24 (3), 1994, s. 707–718, DOI: 10.1017/s0033291700027860, PMID: 7991753.
  • H. Hannerz, P. Borgå, M. Borritz, Life expectancies for individuals with psychiatric diagnoses, „Public Health”, 115 (5), 2001, s. 328–337, DOI: 10.1038/sj.ph.1900785, PMID: 11593442.
  • E.D. Radomsky i inni, Suicidal behavior in patients with schizophrenia and other psychotic disorders, „The American Journal of Psychiatry”, 156 (10), 1999, s. 1590–1595, DOI: 10.1176/ajp.156.10.1590, PMID: 10518171.
  • C.B. Caldwell, I.I. Gottesman, Schizophrenics kill themselves too: a review of risk factors for suicide, „Schizophrenia Bulletin”, 16 (4), 1990, s. 571–589, DOI: 10.1093/schbul/16.4.571, PMID: 2077636.
  • B.A. Pescosolido i inni, The public’s view of the competence, dangerousness, and need for legal coercion of persons with mental health problems, „American Journal of Public Health”, 89 (9), 1999, s. 1339–1345, DOI: 10.2105/ajph.89.9.1339, PMID: 10474550, PMCID: PMC1508769.
  • Elizabeth Walsh, Alec Buchanan, Thomas Fahy, Violence and schizophrenia: examining the evidence, „The British Journal of Psychiatry”, 180, 2002, s. 490–495, DOI: 10.1192/bjp.180.6.490, PMID: 12042226.
  • H.J. Steadman i inni, Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods, „Archives of General Psychiatry”, 55 (5), 1998, s. 393–401, DOI: 10.1001/archpsyc.55.5.393, PMID: 9596041.
  • Jeffrey W. Swanson i inni, A national study of violent behavior in persons with schizophrenia, „Archives of General Psychiatry”, 63 (5), 2006, s. 490–499, DOI: 10.1001/archpsyc.63.5.490, PMID: 16651506.
  • J.W. Swanson i inni, Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys, „Hospital & Community Psychiatry”, 41 (7), 1990, s. 761–770, DOI: 10.1176/ps.41.7.761, PMID: 2142118.
  • Paul E. Mullen, Schizophrenia and violence: from correlations to preventive strategies, „Advances in Psychiatric Treatment”, 12 (4), 2006, s. 239–248, DOI: 10.1192/apt.12.4.239.
  • Alexander I.F. Simpson i inni, Homicide and mental illness in New Zealand, 1970-2000, „The British Journal of Psychiatry”, 185, 2004, s. 394–398, DOI: 10.1192/bjp.185.5.394, PMID: 15516547.
  • Seena Fazel, Martin Grann, Psychiatric morbidity among homicide offenders: a Swedish population study, „The American Journal of Psychiatry”, 161 (11), 2004, s. 2129–2131, DOI: 10.1176/appi.ajp.161.11.2129, PMID: 15514419.
  • J.S. Brekke i inni, Risks for individuals with schizophrenia who are living in the community, „Psychiatric Services”, 52 (10), 2001, s. 1358–1366, DOI: 10.1176/appi.ps.52.10.1358, PMID: 11585953.
  • Paul B. Fitzgerald i inni, Victimization of patients with schizophrenia and related disorders, „The Australian and New Zealand Journal of Psychiatry”, 39 (3), 2005, s. 169–174, DOI: 10.1080/j.1440-1614.2005.01539.x, PMID: 15701066.
  • Elizabeth Walsh i inni, Predicting violence in schizophrenia: a prospective study, „Schizophrenia Research”, 67 (2–3), 2004, s. 247–252, DOI: 10.1016/S0920-9964(03)00091-4, PMID: 14984884.
  • Phyllis L. Solomon, Mary M. Cavanaugh, Richard J. Gelles, Family violence among adults with severe mental illness: a neglected area of research, „Trauma, Violence & Abuse”, 6 (1), 2005, s. 40–54, DOI: 10.1177/1524838004272464, PMID: 15574672.
  • K.R. Chou, R.B. Lu, M. Chang, Assaultive behavior by psychiatric in-patients and its related factors, „The Journal of Nursing Research”, 9 (5), 2001, s. 139–151, DOI: 10.1097/01.jnr.0000347572.60800.00, PMID: 11779087.
  • B. Lögdberg i inni, Schizophrenia, neighbourhood, and crime, „Acta Psychiatrica Scandinavica”, 110 (2), 2004, s. 92–97, DOI: 10.1111/j.1600-0047.2004.00322.x, PMID: 15233709.
  • Tyrone D. Cannon, Barbara Cornblatt, Patrick McGorry, The empirical status of the ultra high-risk (prodromal) research paradigm, „Schizophrenia Bulletin”, 33 (3), 2007, s. 661–664, DOI: 10.1093/schbul/sbm031, PMID: 17470445, PMCID: PMC2526144.
  • Richard J. Drake, Shôn W. Lewis, Early detection of schizophrenia, „Current Opinion in Psychiatry”, 18 (2), 2005, s. 147–150, DOI: 10.1097/00001504-200503000-00007, PMID: 16639167.
  • Nasra Haroun i inni, Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research, „Schizophrenia Bulletin”, 32 (1), 2006, s. 166–178, DOI: 10.1093/schbul/sbj007, PMID: 16207892, PMCID: PMC2632176.
  • Heinz Häfner i inni, Early detection and secondary prevention of psychosis: facts and visions, „European Archives of Psychiatry and Clinical Neuroscience”, 254 (2), 2004, s. 117–128, DOI: 10.1007/s00406-004-0508-z, PMID: 15146341.
  • K. Evans, J. McGrath, R. Milns, Searching for schizophrenia in ancient Greek and Roman literature: a systematic review, „Acta Psychiatrica Scandinavica”, 107 (5), 2003, s. 323–330, DOI: 10.1034/j.1600-0447.2003.00053.x, PMID: 12752027.
  • H.A. Youssef, F.A. Youssef, Evidence for the existence of schizophrenia in medieval Islamic society, „History of Psychiatry”, 7 (25), 1996, s. 55–62, DOI: 10.1177/0957154X9600702503, PMID: 11609215.
  • Roland Kuhn, Eugen Bleuler’s concepts of psychopathology, „History of Psychiatry”, 15 (59 Pt 3), 2004, s. 361–366, DOI: 10.1177/0957154X04044603, PMID: 15386868.
  • G. Stotz-Ingenlath, Epistemological aspects of Eugen Bleuler’s conception of schizophrenia in 1911, „Medicine, Health Care, and Philosophy”, 3 (2), 2000, s. 153–159, DOI: 10.1023/a:1009919309015, PMID: 11079343.
  • G.E. Allen, The social and economic origins of genetic determinism: a case history of the American Eugenics Movement, 1900-1940 and its lessons for today, „Genetica”, 99 (2–3), 1997, s. 77–88, DOI: 10.1007/bf02259511, PMID: 9463076.
  • J.K. Wing, International comparisons in the study of the functional psychoses, „British Medical Bulletin”, 27 (1), 1971, s. 77–81, DOI: 10.1093/oxfordjournals.bmb.a070819, PMID: 4926366.
  • M. Wilson, DSM-III and the transformation of American psychiatry: a history, „The American Journal of Psychiatry”, 150 (3), 1993, s. 399–410, DOI: 10.1176/ajp.150.3.399, PMID: 8434655.

fherehab.com

icanfeelbetter.org

  • CBTp różni się w pewnym stopniu od tradycyjnej CBT. Filmy przedstawiające niektóre techniki CBTp dostępne są na stronie I Can Feel Better.

livingwithschizophreniauk.org

mp.pl

  • Joanna Borowiecka-Kluza: Schizofrenia. Medycyna Praktyczna. [dostęp 2024-03-17].

nice.org.uk

nih.gov

ncbi.nlm.nih.gov

  • D. Castle i inni, The incidence of operationally defined schizophrenia in Camberwell, 1965-84, „The British Journal of Psychiatry”, 159, 1991, s. 790–794, DOI: 10.1192/bjp.159.6.790, PMID: 1790446.
  • Dinesh Bhugra, The global prevalence of schizophrenia, „PLoS Medicine”, 2 (5), 2005, art. nr e151, DOI: 10.1371/journal.pmed.0020151, PMID: 15916460, PMCID: PMC1140960.
  • Elliot M. Goldner i inni, Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature, „Canadian Journal of Psychiatry”, 47 (9), 2002, s. 833–843, DOI: 10.1177/070674370204700904, PMID: 12500753.
  • Georg Schomerus i inni, The association of schizophrenia with split personality is not an ubiquitous phenomenon: results from population studies in Russia and Germany, „Social Psychiatry and Psychiatric Epidemiology”, 42 (10), 2007, s. 780–786, DOI: 10.1007/s00127-007-0235-7, PMID: 17660932.
  • S. Brown, H. Inskip, B. Barraclough, Causes of the excess mortality of schizophrenia, „The British Journal of Psychiatry”, 177, 2000, s. 212–217, DOI: 10.1192/bjp.177.3.212, PMID: 11040880.
  • A. Jablensky i inni, Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study, „Psychological Medicine. Monograph Supplement”, 20, 1992, s. 1–97, DOI: 10.1017/s0264180100000904, PMID: 1565705.
  • James B. Kirkbride i inni, Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study, „Archives of General Psychiatry”, 63 (3), 2006, s. 250–258, DOI: 10.1001/archpsyc.63.3.250, PMID: 16520429.
  • James B. Kirkbride i inni, Neighbourhood variation in the incidence of psychotic disorders in Southeast London, „Social Psychiatry and Psychiatric Epidemiology”, 42 (6), 2007, s. 438–445, DOI: 10.1007/s00127-007-0193-0, PMID: 17473901.
  • John McGrath i inni, A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology, „BMC Medicine”, 2, 2004, s. 13, DOI: 10.1186/1741-7015-2-13, PMID: 15115547, PMCID: PMC421751.
  • Paul J. Scully i inni, First-episode schizophrenia, bipolar disorder and other psychoses in a rural Irish catchment area: incidence and gender in the Cavan-Monaghan study at 5 years, „The British Journal of Psychiatry. Supplement”, 43, 2002, s3–9, DOI: 10.1192/bjp.181.43.s3, PMID: 12271797.
  • Geoffrey Davies i inni, A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia, „Schizophrenia Bulletin”, 29 (3), 2003, s. 587–593, DOI: 10.1093/oxfordjournals.schbul.a007030, PMID: 14609251.
  • T.B. Ustün i inni, Multiple-informant ranking of the disabling effects of different health conditions in 14 countries. WHO/NIH Joint Project CAR Study Group, „The Lancet”, 354 (9173), 1999, s. 111–115, DOI: 10.1016/s0140-6736(98)07507-2, PMID: 10408486.
  • S. Kumra i inni, Childhood-onset schizophrenia: research update, „Canadian Journal of Psychiatry”, 46 (10), 2001, s. 923–930, DOI: 10.1177/070674370104601004, PMID: 11816313.
  • H. Remschmidt, F.M. Theisen, Schizophrenia and related disorders in children and adolescents, „Journal of Neural Transmission. Supplementum” (69), 2005, s. 121–141, DOI: 10.1007/3-211-31222-6_7, PMID: 16355606.
  • Aksel Bertelsen, Schizophrenia and related disorders: experience with current diagnostic systems, „Psychopathology”, 35 (2–3), 2002, s. 89–93, DOI: 10.1159/000065125, PMID: 12145490.
  • Jeffrey A. Lieberman i inni, Effectiveness of antipsychotic drugs in patients with chronic schizophrenia, „The New England Journal of Medicine”, 353 (12), 2005, s. 1209–1223, DOI: 10.1056/NEJMoa051688, PMID: 16172203.
  • R.A. Dickson i inni, Risperidone-induced prolactin elevations in premenopausal women with schizophrenia, „The American Journal of Psychiatry”, 152 (7), 1995, s. 1102–1103, DOI: 10.1176/ajp.152.7.1102b, PMID: 7540803.
  • Jambur Ananth i inni, Neuroleptic malignant syndrome and atypical antipsychotic drugs, „The Journal of Clinical Psychiatry”, 65 (4), 2004, s. 464–470, DOI: 10.4088/jcp.v65n0403, PMID: 15119907.
  • Jason M Noel, Cherry W Jackson, ASHP therapeutic position statement on the use of antipsychotic medications in the treatment of adults with schizophrenia and schizoaffective disorder, „American Journal of Health-System Pharmacy”, 77 (24), 2020, s. 2114–2132, DOI: 10.1093/ajhp/zxaa303, ISSN 1079-2082, PMID: 32871013, PMCID: PMC7499485.
  • Stefan Leucht i inni, New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis, „The Lancet”, 361 (9369), 2003, s. 1581–1589, DOI: 10.1016/S0140-6736(03)13306-5, PMID: 12747876.
  • H.Y. Meltzer, Treatment-resistant schizophrenia--the role of clozapine, „Current Medical Research and Opinion”, 14 (1), 1997, s. 1–20, DOI: 10.1185/03007999709113338, PMID: 9524789.
  • K. Wahlbeck, M. Cheine, M.A. Essali, Clozapine versus typical neuroleptic medication for schizophrenia, „The Cochrane Database of Systematic Reviews” (2), 2000, CD000059, DOI: 10.1002/14651858.CD000059, PMID: 10796289.
  • Steven J. Haas i inni, Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003, „Drug Safety”, 30 (1), 2007, s. 47–57, DOI: 10.2165/00002018-200730010-00005, PMID: 17194170.
  • M.L. Lee i inni, Clozapine and substance abuse in patients with schizophrenia, „Canadian Journal of Psychiatry”, 43 (8), 1998, s. 855–856, PMID: 9806095.
  • Marlene P. Freeman i inni, Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry, „The Journal of Clinical Psychiatry”, 67 (12), 2006, s. 1954–1967, DOI: 10.4088/jcp.v67n1217, PMID: 17194275.
  • I. Cormac, C. Jones, C. Campbell, Cognitive behaviour therapy for schizophrenia, „The Cochrane Database of Systematic Reviews” (1), 2002, art. nr CD000524, DOI: 10.1002/14651858.CD000524, PMID: 11869579.
  • G. Zimmermann i inni, The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: a meta-analysis, „Schizophrenia Research”, 77 (1), 2005, s. 1–9, DOI: 10.1016/j.schres.2005.02.018, PMID: 16005380.
  • Til Wykes i inni, Effects on the brain of a psychological treatment: cognitive remediation therapy: functional magnetic resonance imaging in schizophrenia, „The British Journal of Psychiatry”, 181, 2002, s. 144–152, DOI: 10.1017/s0007125000161872, PMID: 12151286.
  • Gerard E. Hogarty i inni, Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior, „Archives of General Psychiatry”, 61 (9), 2004, s. 866–876, DOI: 10.1001/archpsyc.61.9.866, PMID: 15351765.
  • William R. McFarlane i inni, Family psychoeducation and schizophrenia: a review of the literature, „Journal of Marital and Family Therapy”, 29 (2), 2003, s. 223–245, DOI: 10.1111/j.1752-0606.2003.tb01202.x, PMID: 12728780.
  • Shirley M. Glynn, Amy N. Cohen, Noosha Niv, New challenges in family interventions for schizophrenia, „Expert Review of Neurotherapeutics”, 7 (1), 2007, s. 33–43, DOI: 10.1586/14737175.7.1.33, PMID: 17187495.
  • Alex Kopelowicz, Robert Paul Liberman, Roberto Zarate, Recent advances in social skills training for schizophrenia, „Schizophrenia Bulletin”, 32 Suppl 1, 2006, s. S12–S23, DOI: 10.1093/schbul/sbl023, PMID: 16885207, PMCID: PMC2632540.
  • Nakul Talwar i inni, Music therapy for in-patients with schizophrenia: exploratory randomised controlled trial, „The British Journal of Psychiatry”, 189, 2006, s. 405–409, DOI: 10.1192/bjp.bp.105.015073, PMID: 17077429.
  • Dafna Regev, Liat Cohen-Yatziv, Effectiveness of art therapy with adult clients in 2018—what progress has been made?, „Frontiers in Psychology”, 9, 2018, DOI: 10.3389/fpsyg.2018.01531, ISSN 1664-1078, PMID: 30210388, PMCID: PMC6124538.
  • J. Greenhalgh i inni, Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies, „Health Technology Assessment”, 9 (9), 2005, s. 1–156, DOI: 10.3310/hta9090, PMID: 15774232.
  • George A. Mashour, Erin E. Walker, Robert L. Martuza, Psychosurgery: past, present, and future, „Brain Research. Brain Research Reviews”, 48 (3), 2005, s. 409–419, DOI: 10.1016/j.brainresrev.2004.09.002, PMID: 15914249 [dostęp 2020-05-01].
  • Paula Goering i inni, Who uses consumer-run self-help organizations?, „The American Journal of Orthopsychiatry”, 76 (3), 2006, s. 367–373, DOI: 10.1037/0002-9432.76.3.367, PMID: 16981815.
  • L. Davidson, T.H. McGlashan, The varied outcomes of schizophrenia, „Canadian Journal of Psychiatry”, 42 (1), 1997, s. 34–43, DOI: 10.1177/070674379704200105, PMID: 9040921.
  • J.A. Lieberman i inni, Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia, „The Journal of Clinical Psychiatry”, 57 Suppl 9, 1996, s. 5–9, PMID: 8823344.
  • G. Harrison i inni, Recovery from psychotic illness: a 15- and 25-year international follow-up study, „The British Journal of Psychiatry”, 178, 2001, s. 506–517, DOI: 10.1192/bjp.178.6.506, PMID: 11388966.
  • C.M. Harding i inni, The Vermont longitudinal study of persons with severe mental illness, II: Long-term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia, „The American Journal of Psychiatry”, 144 (6), 1987, s. 727–735, DOI: 10.1176/ajp.144.6.727, PMID: 3591992.
  • Delbert G. Robinson i inni, Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder, „The American Journal of Psychiatry”, 161 (3), 2004, s. 473–479, DOI: 10.1176/appi.ajp.161.3.473, PMID: 14992973.
  • Carol A. Harvey i inni, The Camden Schizophrenia Surveys. III: Five-year outcome of a sample of individuals from a prevalence survey and the importance of social relationships, „The International Journal of Social Psychiatry”, 53 (4), 2007, s. 340–356, DOI: 10.1177/0020764006074529, PMID: 17703650.
  • K. Hopper, J. Wanderling, Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: results from ISoS, the WHO collaborative followup project. International Study of Schizophrenia, „Schizophrenia Bulletin”, 26 (4), 2000, s. 835–846, DOI: 10.1093/oxfordjournals.schbul.a033498, PMID: 11087016.
  • P. Bebbington, L. Kuipers, The predictive utility of expressed emotion in schizophrenia: an aggregate analysis, „Psychological Medicine”, 24 (3), 1994, s. 707–718, DOI: 10.1017/s0033291700027860, PMID: 7991753.
  • H. Hannerz, P. Borgå, M. Borritz, Life expectancies for individuals with psychiatric diagnoses, „Public Health”, 115 (5), 2001, s. 328–337, DOI: 10.1038/sj.ph.1900785, PMID: 11593442.
  • E.D. Radomsky i inni, Suicidal behavior in patients with schizophrenia and other psychotic disorders, „The American Journal of Psychiatry”, 156 (10), 1999, s. 1590–1595, DOI: 10.1176/ajp.156.10.1590, PMID: 10518171.
  • C.B. Caldwell, I.I. Gottesman, Schizophrenics kill themselves too: a review of risk factors for suicide, „Schizophrenia Bulletin”, 16 (4), 1990, s. 571–589, DOI: 10.1093/schbul/16.4.571, PMID: 2077636.
  • B.A. Pescosolido i inni, The public’s view of the competence, dangerousness, and need for legal coercion of persons with mental health problems, „American Journal of Public Health”, 89 (9), 1999, s. 1339–1345, DOI: 10.2105/ajph.89.9.1339, PMID: 10474550, PMCID: PMC1508769.
  • Elizabeth Walsh, Alec Buchanan, Thomas Fahy, Violence and schizophrenia: examining the evidence, „The British Journal of Psychiatry”, 180, 2002, s. 490–495, DOI: 10.1192/bjp.180.6.490, PMID: 12042226.
  • Heather Stuart, Violence and mental illness: an overview, „World Psychiatry”, 2 (2), 2003, s. 121–124, PMID: 16946914, PMCID: PMC1525086.
  • H.J. Steadman i inni, Violence by people discharged from acute psychiatric inpatient facilities and by others in the same neighborhoods, „Archives of General Psychiatry”, 55 (5), 1998, s. 393–401, DOI: 10.1001/archpsyc.55.5.393, PMID: 9596041.
  • Jeffrey W. Swanson i inni, A national study of violent behavior in persons with schizophrenia, „Archives of General Psychiatry”, 63 (5), 2006, s. 490–499, DOI: 10.1001/archpsyc.63.5.490, PMID: 16651506.
  • J.W. Swanson i inni, Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys, „Hospital & Community Psychiatry”, 41 (7), 1990, s. 761–770, DOI: 10.1176/ps.41.7.761, PMID: 2142118.
  • Alexander I.F. Simpson i inni, Homicide and mental illness in New Zealand, 1970-2000, „The British Journal of Psychiatry”, 185, 2004, s. 394–398, DOI: 10.1192/bjp.185.5.394, PMID: 15516547.
  • Seena Fazel, Martin Grann, Psychiatric morbidity among homicide offenders: a Swedish population study, „The American Journal of Psychiatry”, 161 (11), 2004, s. 2129–2131, DOI: 10.1176/appi.ajp.161.11.2129, PMID: 15514419.
  • J.S. Brekke i inni, Risks for individuals with schizophrenia who are living in the community, „Psychiatric Services”, 52 (10), 2001, s. 1358–1366, DOI: 10.1176/appi.ps.52.10.1358, PMID: 11585953.
  • Paul B. Fitzgerald i inni, Victimization of patients with schizophrenia and related disorders, „The Australian and New Zealand Journal of Psychiatry”, 39 (3), 2005, s. 169–174, DOI: 10.1080/j.1440-1614.2005.01539.x, PMID: 15701066.
  • Elizabeth Walsh i inni, Predicting violence in schizophrenia: a prospective study, „Schizophrenia Research”, 67 (2–3), 2004, s. 247–252, DOI: 10.1016/S0920-9964(03)00091-4, PMID: 14984884.
  • Phyllis L. Solomon, Mary M. Cavanaugh, Richard J. Gelles, Family violence among adults with severe mental illness: a neglected area of research, „Trauma, Violence & Abuse”, 6 (1), 2005, s. 40–54, DOI: 10.1177/1524838004272464, PMID: 15574672.
  • K.R. Chou, R.B. Lu, M. Chang, Assaultive behavior by psychiatric in-patients and its related factors, „The Journal of Nursing Research”, 9 (5), 2001, s. 139–151, DOI: 10.1097/01.jnr.0000347572.60800.00, PMID: 11779087.
  • B. Lögdberg i inni, Schizophrenia, neighbourhood, and crime, „Acta Psychiatrica Scandinavica”, 110 (2), 2004, s. 92–97, DOI: 10.1111/j.1600-0047.2004.00322.x, PMID: 15233709.
  • Tyrone D. Cannon, Barbara Cornblatt, Patrick McGorry, The empirical status of the ultra high-risk (prodromal) research paradigm, „Schizophrenia Bulletin”, 33 (3), 2007, s. 661–664, DOI: 10.1093/schbul/sbm031, PMID: 17470445, PMCID: PMC2526144.
  • Richard J. Drake, Shôn W. Lewis, Early detection of schizophrenia, „Current Opinion in Psychiatry”, 18 (2), 2005, s. 147–150, DOI: 10.1097/00001504-200503000-00007, PMID: 16639167.
  • Jim Van Os, Philippe Delespaul, Toward a world consensus on prevention of schizophrenia, „Dialogues in Clinical Neuroscience”, 7 (1), 2005, s. 53–67, PMID: 16060596, PMCID: PMC3181724.
  • Nasra Haroun i inni, Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research, „Schizophrenia Bulletin”, 32 (1), 2006, s. 166–178, DOI: 10.1093/schbul/sbj007, PMID: 16207892, PMCID: PMC2632176.
  • Heinz Häfner i inni, Early detection and secondary prevention of psychosis: facts and visions, „European Archives of Psychiatry and Clinical Neuroscience”, 254 (2), 2004, s. 117–128, DOI: 10.1007/s00406-004-0508-z, PMID: 15146341.
  • K. Evans, J. McGrath, R. Milns, Searching for schizophrenia in ancient Greek and Roman literature: a systematic review, „Acta Psychiatrica Scandinavica”, 107 (5), 2003, s. 323–330, DOI: 10.1034/j.1600-0447.2003.00053.x, PMID: 12752027.
  • H.A. Youssef, F.A. Youssef, Evidence for the existence of schizophrenia in medieval Islamic society, „History of Psychiatry”, 7 (25), 1996, s. 55–62, DOI: 10.1177/0957154X9600702503, PMID: 11609215.
  • Roland Kuhn, Eugen Bleuler’s concepts of psychopathology, „History of Psychiatry”, 15 (59 Pt 3), 2004, s. 361–366, DOI: 10.1177/0957154X04044603, PMID: 15386868.
  • G. Stotz-Ingenlath, Epistemological aspects of Eugen Bleuler’s conception of schizophrenia in 1911, „Medicine, Health Care, and Philosophy”, 3 (2), 2000, s. 153–159, DOI: 10.1023/a:1009919309015, PMID: 11079343.
  • G.E. Allen, The social and economic origins of genetic determinism: a case history of the American Eugenics Movement, 1900-1940 and its lessons for today, „Genetica”, 99 (2–3), 1997, s. 77–88, DOI: 10.1007/bf02259511, PMID: 9463076.
  • J.K. Wing, International comparisons in the study of the functional psychoses, „British Medical Bulletin”, 27 (1), 1971, s. 77–81, DOI: 10.1093/oxfordjournals.bmb.a070819, PMID: 4926366.
  • M. Wilson, DSM-III and the transformation of American psychiatry: a history, „The American Journal of Psychiatry”, 150 (3), 1993, s. 399–410, DOI: 10.1176/ajp.150.3.399, PMID: 8434655.

psychiatryonline.org

psychodyssey.net

web.archive.org

webcitation.org

who.int

  • Angelo Barbato: Schizophrenia and public health. Geneva: World Health Organization, 1998, s. 8–17. Cytat: ang. „about 45% recover after one or more episodes [...] and 35% show a mixed pattern with varying degrees of remission and exacerbations of different length. [...] Risk of relapse during the first year following an acute episode in patients on antipsychotic medications is reduced to about 20%, in comparison with about 60% on placebo.”..

worldcat.org

  • Joachim Kowalski, Katarzyna Szaulińska, Marek Jarema, In search of a definition of the term "psychotic process" - thoughts and doubts, „Psychiatria Polska”, 51 (2), 2017, s. 383–386, DOI: 10.12740/pp/69387, ISSN 0033-2674 [dostęp 2021-05-25] (pol.).
  • Jason M Noel, Cherry W Jackson, ASHP therapeutic position statement on the use of antipsychotic medications in the treatment of adults with schizophrenia and schizoaffective disorder, „American Journal of Health-System Pharmacy”, 77 (24), 2020, s. 2114–2132, DOI: 10.1093/ajhp/zxaa303, ISSN 1079-2082, PMID: 32871013, PMCID: PMC7499485.
  • Dafna Regev, Liat Cohen-Yatziv, Effectiveness of art therapy with adult clients in 2018—what progress has been made?, „Frontiers in Psychology”, 9, 2018, DOI: 10.3389/fpsyg.2018.01531, ISSN 1664-1078, PMID: 30210388, PMCID: PMC6124538.
  • Tim Requarth, Choroba psychiczna pod lupą, „Świat Nauki”, nr. 9 (241), Prószyński Media, wrzesień 2011, s. 6, ISSN 0867-6380.